Back to Market Feed

Product Information

PENTAZOCINE-NALOXONE TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $2.0619 per EA under NDC 00591039501. Its NADAC has been published 579 times since Nov 28, 2013.

FDA first approved this application on Jan 21, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PENTAZOCINE-NALOXONE TABLET

Pentazocine hydrochloride and naloxone hydrochloride
$2.0619per EA
DEA Schedule CIV

Strength

.5; 50 mg/1; mg/1

NDC

00591039501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA074736

FDA Approved

1/21/1997

TE Code

AB

On Market Since

5/21/1997

Pharmacological Classes

Competitive Opioid Antagonists
Opioid Antagonist
Opioid Antagonists
Partial Opioid Agonist/Antagonist
Partial Opioid Agonists

Price Statistics

The NADAC for PENTAZOCINE-NALOXONE TABLET has been published 579 times since Nov 28, 2013, and over the history we have for it it has risen 104.4%. The table below summarizes its recorded NADAC range and movement.

Current price$2.0619 per EA
All-time high$2.1945 (Aug 12, 2015)
All-time low$1.0089 (Nov 28, 2013)
52-week high$2.0619
52-week low$1.9526
Median price$1.9141
Average price$1.8498
Largest weekly change+61.0% (Aug 20, 2014)
Weeks tracked579
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

+2.1%

6M

+4.5%

1Y

+3.6%

3Y

+9.1%

5Y

+13.1%

All

+104.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Pentazocine hydrochloride and naloxone hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

BUPRENORPHINE 2 MG TABLET SL
Generic
00054017613•Hikma Pharmaceuticals USA Inc.
$0.2648
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
00121101930•PAI Holdings LLC
$0.2648
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
00228315603•Actavis Pharma, Inc.
$0.2648
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
00904715404•Major Pharmaceuticals
$0.2648
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
42858050103•Rhodes Pharmaceuticals L.P.
$0.2648
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
50268012815•AvPAK
$0.2648
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
60687048121•American Health Packaging
$0.2648
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
62756045983•Sun Pharmaceutical Industries Inc.
$0.2648
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
72888018230•Advagen Pharma Ltd.
$0.2648
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00054018813•Hikma Pharmaceuticals USA Inc.
$0.4620
per EA

Frequently asked questions

What is the NADAC price of PENTAZOCINE-NALOXONE TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PENTAZOCINE-NALOXONE TABLET, manufactured by Actavis Pharma, Inc., is $2.0619 per EA (NDC 00591039501), effective Aug 19, 2026.

How has the price of PENTAZOCINE-NALOXONE TABLET changed over time?

Over the history we have for it, the NADAC for PENTAZOCINE-NALOXONE TABLET has risen 104.4%. It has been tracked across 579 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PENTAZOCINE-NALOXONE TABLET?

Since Nov 28, 2013, the NADAC for PENTAZOCINE-NALOXONE TABLET has ranged from a low of $1.0089 (Nov 28, 2013) to a high of $2.1945 (Aug 12, 2015), with a median of $1.9141 per EA.

Are there cheaper alternatives to PENTAZOCINE-NALOXONE TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PENTAZOCINE-NALOXONE TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PENTAZOCINE-NALOXONE TABLET?

PENTAZOCINE-NALOXONE TABLET (NDC 00591039501) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.